88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business Acquisition supports Servier's strategic ambition in rare neurology for patients with high unmet medical needs. Transaction includes sevasemten, a late-stage investigational treatment for ... 2026-06-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
3billion Launches 3B-NEO, a Genomic Newborn Screening Service Covering 595 Clinically Actionable Genetic Conditions Screens 595 carefully selected genes associated with childhood-onset conditions where early intervention may improve outcomes Designed for maternity hospitals, obstetrics practices, newborn care providers, ... 2026-06-01T Biotechnology Computer/Electronics Health Care/Hospital Medical Equipment
Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research Delivers up to 20x improvement in MS/MS sensitivity and 2x faster acquisition speeds, enabling deeper biological insight for next-generation multiomics, therapeutic, and high-throughput workflows. ... 2026-06-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics >10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals. ... 2026-06-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
/C O R R E C T I O N -- Ranok Therapeutics/ In the news release, Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic Non-Small Cell Lung Cancer Presented At ... 2026-06-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Biond Biologics and Guangzhou-Israel Biotechnology Fund ("GIBF") Announce Closing of $8 Million Investment and Collaboration Biond Biologics and Guangzhou-Israel Biotechnology Fund (GIBF) Announce Strategic Investment and Joint Venture to Advance First-in-Class Oncology Programs in China ... 2026-06-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ebola disease in Democratic Republic of Congo: MSF scales up response to a rapidly evolving outbreak HONG KONG , June 1, 2026 /PRNewswire/ -- In eastern Democratic Republic of Congo (DRC), people have been living through insecurity and with an under-resourced health system for years. The Ebola disease ... 2026-06-01T Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas SILICON VALLEY, Calif. and BEIJING , June 1, 2026 /PRNewswire/ -- On May 29, 2026, Haisco Pharmaceutical Group Co., Ltd. ("Haisco") (Ticker Code: 002653) announced a licensing and research ... 2026-06-01T Health Care/Hospital Medical/Pharmaceuticals
Smartee Mandibular Advancement Repositioning Seminar Draws Active Clinical Dialogue in Tokyo TOKYO , May 30, 2026 /PRNewswire/ -- Smartee Denti-Technology , a global provider of clear aligner solutions, recently held a two-day Certified Seminar on Mandibular Advancement Repositioning Technology ... 2026-06-01T Computer/Electronics Health Care/Hospital Trade show news
China's Original Innovative Drug Cipepofol Approved for Marketing by the U.S. FDA BEIJING , June 1, 2026 /PRNewswire/ -- Cipepofol (CYPSEDO) Injection (hereinafter "Cipepofol"), a Class 1 innovative intravenous anesthetic independently developed by Haisco Pharmaceutical ... 2026-06-01T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved